Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Experimental Medicine|April 13, 2018
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformationReina Nagase, Daichi Inoue, Alessandro Pastore, et al.
Cell Reports|August 3, 2024
SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiationYu-Hsuan Chang, Keita Yamamoto, Takeshi Fujino, et al.
Cancer Discovery|August 11, 2025
Systematic evaluation of GAPs and GEFs identifies a targetable dependency for hematopoietic malignanciesPu Zhang, Zhendong Cao, Xiangyu Pan, et al.
Leukemia|March 21, 2018
A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignanciesDaichi Inoue, Takeshi Fujino, Paul Sheridan, et al.
Cancer Immunology Research|July 3, 2024
Augmenting CAR T-cell Functions with LIGHTWinson Cai, Kento Tanaka, Xiaoli Mi, et al.
Nature Communications|March 24, 2021
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathwayTakeshi Fujino, Susumu Goyama, Yuki Sugiura, et al.
Nature Cardiovascular Research|December 9, 2024
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunityNaru Sato, Susumu Goyama, Yu-Hsuan Chang, et al.
EMBO Molecular Medicine|December 1, 2022
IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemiaXiaoxiao Liu, Naru Sato, Tomohiro Yabushita, et al.
Pageof 7